The efficacy of adding budesonide/formoterol to ipratropium plus theophylline in managing severe chronic obstructive pulmonary disease: an open-label, randomized study in China

BACKGROUND: Patients diagnosed with chronic obstructive pulmonary disease (COPD) in China are commonly prescribed ipratropium plus theophylline (I+T) therapy. Studies have shown that an inhaled corticosteroid (ICS)/long-acting β(2)-agonist (LABA) combination is also efficacious in reducing symptoms...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Kewu, Guo, Yanfei, Kang, Jian, An, Li, Zheng, Zeguang, Ma, Lijun, Peng, Liping, Wang, Hongyang, Su, Rong, Itoh, Yohji, Wang, Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595664/
https://www.ncbi.nlm.nih.gov/pubmed/31240995
http://dx.doi.org/10.1177/1753466619853500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595664/
https://www.ncbi.nlm.nih.gov/pubmed/31240995
http://dx.doi.org/10.1177/1753466619853500

Ejemplares similares